LinagliptinDPP-4 Inhibitor (Antidiabetic Preparations) Indication: Management of type 2 diabetes mellitus. Dosage & Administration: The recommended dose of Linita™ is one tablet once daily. No dosage adjustment is required in patients with type 2 diabetes having renal or hepatic impairment Preparation: Linita™ Tablet: Box containing 30 tablets in blister pack.